MedPath

Genomas, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

DNA Diagnostic System for Statin Safety and Efficacy

Conditions
Hypercholesterolemia
Myopathy
First Posted Date
2008-10-06
Last Posted Date
2008-10-06
Lead Sponsor
Genomas, Inc
Target Recruit Count
750
Registration Number
NCT00767130
Locations
🇺🇸

University of California-San Francisco, San Francisco, California, United States

🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

🇺🇸

Rogosin Institute, New York Presbyterian Hospital, New York, New York, United States

DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

Conditions
Psychoses
First Posted Date
2008-09-16
Last Posted Date
2008-09-16
Lead Sponsor
Genomas, Inc
Target Recruit Count
1000
Registration Number
NCT00752960
Locations
🇺🇸

Hartford Hospital Institute of Living, Hartford, Connecticut, United States

🇺🇸

University of Kentucky, Lexington, Kentucky, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.